Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology June 2022 10(6):393-406 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587